U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07872397) titled 'Glycemic Variability After SASI Versus Roux-en-Y Gastric Bypass' on Oct. 07.
Brief Summary: The GLUBARI trial is a prospective, randomized, single-center clinical study comparing two bariatric surgical procedures in adults with morbid obesity: Single Anastomosis Sleeve Ileal Bypass (SASI) and Roux-en-Y Gastric Bypass (RYGB). The main objective is to compare glycemic variability between the two procedures using continuous glucose monitoring. Participants will undergo continuous glucose monitoring for 7 days before surgery and again at 6 and 12 months after surgery. Secondary outcomes include hypoglycemic events, weight loss, resoluti...